Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical ...
Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a ...
New data from ADA 2026 reveal that assumptions around age, weight, and gestational history are leaving too many T1D patients misclassified — and the clinical consequences are preventable. Our modern ...
Collaboration underscores interest in inhaled insulin and strengthens bringing innovation and new options to pediatric diabetes care DANBURY, Conn. and WESTLAKE VILLAGE, Calif., June 23, 2026 (GLOBE ...
Under the terms of MacroGenics’ agreement with Sanofi, the recent FDA approval triggered a $24.5 million regulatory milestone payable to MacroGenics. The Company remains eligible to receive up to $305 ...
NEW YORK, June 12, 2026 /PRNewswire/ -- Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today's decision from the U.S. Food and Drug ...
Add Yahoo as a preferred source to see more of our stories on Google. AGAWAM, Mass. (WWLP) – The Breakthrough T1D walk was held Sunday morning to help raise funds and raise awareness for those with ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen by an independent group of researchers. The Nature Index provides absolute Count of ...
(WXYZ) — Breakthrough T1D, formerly known as JDRF, is hosting its annual Detroit Promise Ball on Friday, May 15, at Michigan Central Station. The annual ball helps ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results